Year-End Termination

KEANEY CONSULTING INC. for NOVARTIS VACCINES AND DIAGNOSTICS INC

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

Prescription drug user fees International drug pricing Pediatric drug legislation Blood testing issues

LobbyistCovered position, as disclosed
DAVID - KEANEY N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Prescription drug user fees International drug pricing Pediatric drug legislation Blood testing issues

LobbyistCovered position, as disclosed
DAVID - KEANEY N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Prescription drug user fees International drug pricing Pediatric drug legislation Blood testing issues

LobbyistCovered position, as disclosed
DAVID - KEANEY N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Prescription drug user fees International drug pricing Pediatric drug legislation Blood testing issues

LobbyistCovered position, as disclosed
DAVID - KEANEY N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Government Issues GOV

Prescription drug user fees International drug pricing Pediatric drug legislation Blood testing issues

LobbyistCovered position, as disclosed
DAVID - KEANEY N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.